RISK-FACTORS THAT ATTENUATE THE FEMALE CORONARY-DISEASE ADVANTAGE

被引:287
作者
KANNEL, WB [1 ]
WILSON, PWF [1 ]
机构
[1] BOSTON UNIV,SCH MED,EVANS MEM RES FDN,DEPT MED,PREVENT MED & EPIDEMIOL SECT,BOSTON,MA 02118
关键词
D O I
10.1001/archinte.155.1.57
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To compare the coronary disease experience of men and women in a community setting. Design end Setting: Prospective cohort study. Patients: Long-term follow-up of a population-based sample of 5209 men and women. Results: Women outlive men and experience fewer cardiovascular events. By middle age, women lag 20 years behind men in the incidence of myocardial infarction, but the gap closes in the elderly, when cardiovascular disease becomes the leading cause of death in women as well as in men. Menopause promptly escalates coronary disease risk threefold and greatly erodes the advantage over men. Women and men share the same major risk factors for coronary disease, although women experience a lower absolute risk. However, high ratios of total/high-density lipoprotein cholesterol level ratios, left ventricular hypertrophy, and diabetes tend to eliminate the female advantage. Conclusion: Coronary disease is not a minor problem in women. Consequently, women should take vigorous preventive measures. There is a need for particular attention to glucose tolerance and blood lipid levels and a greater sense of urgency when hypertension progresses to left ventricular hypertrophy.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 13 条
[1]   AN UPDATED CORONARY RISK PROFILE - A STATEMENT FOR HEALTH-PROFESSIONALS [J].
ANDERSON, KM ;
WILSON, PWF ;
ODELL, PM ;
KANNEL, WB .
CIRCULATION, 1991, 83 (01) :356-362
[2]   EFFECTS OF THERAPY WITH CHOLESTYRAMINE ON PROGRESSION OF CORONARY ARTERIOSCLEROSIS - RESULTS OF THE NHLBI TYPE-II CORONARY INTERVENTION STUDY [J].
BRENSIKE, JF ;
LEVY, RI ;
KELSEY, SF ;
PASSAMANI, ER ;
RICHARDSON, JM ;
LOH, IK ;
STONE, NJ ;
ALDRICH, RF ;
BATTAGLINI, JW ;
MORIARTY, DJ ;
FISHER, MR ;
FRIEDMAN, L ;
FRIEDEWALD, W ;
DETRE, KM ;
EPSTEIN, SE .
CIRCULATION, 1984, 69 (02) :313-324
[3]  
CASTELL WP, 1988, AM J OBSTET GYNECOL, V158, P1153
[4]  
CUPPLES LA, 1987, NIH872703 US DEP COM
[5]  
FEINLEIB M, 1986, CORONARY HEART DISEA, P29
[6]   HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].
GORDON, T ;
CASTELLI, WP ;
HJORTLAND, MC ;
KANNEL, WB ;
DAWBER, TR .
AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714
[7]   REGRESSION OF CORONARY ATHEROSCLEROSIS DURING TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA WITH COMBINED DRUG REGIMENS [J].
KANE, JP ;
MALLOY, MJ ;
PORTS, TA ;
PHILLIPS, NR ;
DIEHL, JC ;
HAVEL, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (23) :3007-3012
[8]  
Kannel W B, 1979, Diabetes Care, V2, P120, DOI 10.2337/diacare.2.2.120
[9]   MENOPAUSE AND RISK OF CARDIOVASCULAR-DISEASE - FRAMINGHAM STUDY [J].
KANNEL, WB ;
HJORTLAND, MC ;
MCNAMARA, PM ;
GORDON, T .
ANNALS OF INTERNAL MEDICINE, 1976, 85 (04) :447-452